OUR PRODUCTS

MOBILE APPS

GENERAL INFO

RARE

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Ultragenyx Pharmaceutical (RARE) Earnings Date & Reports

Ultragenyx Pharmaceutical Inc is a USA-based biopharmaceutical company... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

RARE is expected to report earnings to rise 5.98% to -124 cents per share on November 04

Ultragenyx Pharmaceutical RARE Stock Earnings Reports

Q3'25

Est.

$-1.24

Q2'25

Beat

by $0.13

Q1'25

Missed

by $0.01

Q4'24

Missed

by $0.05

Q3'24

Beat

by $0.08

The last earnings report on August 05 showed earnings per share of -116 cents, beating the estimate of -129 cents. With 1.35M shares outstanding, the current market capitalization sits at 2.86B.

View a ticker or compare two or three

Compare

RARE

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For RARE
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. RARE showed earnings on August 05, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

a developer of therapeutics for rare diseases

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

60 Leveroni Court

Phone

+1 415 483-8800

Employees

1276

Web

https://www.ultragenyx.com